Advanced Practice Provider–Led Models in Screening, Treatment, and Care Delivery

Nov 08 2026
Convention Center: Bluebird Ballroom 2DEF
9:45 AM - 10:45 AM
Captured/recorded session Recorded
CE Credits CE Credits

Description

This session highlights the expanding role of advanced practice providers in hepatology, with a focus on MASLD screening, pharmacotherapy implementation, and care delivery innovation. Topics include APP-led lifestyle interventions, pharmacist- and nurse practitioner–driven treatment pathways, AI-assisted diagnostic tools, and the intersection of liver disease with menopause and hormonal therapy.

Presentations

9:45 AM - 10:00 AM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

Menopause in Women with Liver Disease: Symptom Burden, Metabolic Changes, and Hormonal Replacement Therapy use 

Lorrinda Gray-Davis | Abstract Presenter
10:00 AM - 10:15 AM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

LiteMedSAM and MedNet: A Segmentation-Assisted, Attention-Guided Lightweight Framework for Edge-Deployable Sonographic Classification of Hepatocellular Carcinoma

Jansi Sethuraj, BSN DNP RN CCRN APRN | Abstract Presenter
10:15 AM - 10:30 AM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

Practice challenges facing advanced practice providers in managing MASLD patients on resmetirom: Experience of a single non-academic, community-based liver center

Anna M Hefner, PhD, FAASLD | Abstract Presenter
10:30 AM - 10:45 AM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

Using Interpretable Machine Learning Model to Predict Health-Related Quality of Life in Patients with MASLD

Wen Li | Abstract Presenter

Objectives

  • Describe APP-led care models for MASLD screening and linkage to care, including automated case-finding, FibroScan referral pathways, and lifestyle intervention programs
  • Discuss pharmacist-led implementation of emerging MASLD therapies, including resmetirom practice guidance and real-world semaglutide outcomes in subspecialty clinics
  • Identify complementary tools and considerations in APP-driven hepatology practice, including AI-based sonographic classification of hepatocellular carcinoma and the management of menopause-related symptoms in women with liver disease